IN BRIEF: Poolbeg Pharma raises GBP3.5 million in share placing
15th Jul 2026 06:59
Poolbeg Pharma PLC - London-based biopharmaceutical firm focused on cancer immunotherapy - Raises GBP3.5 million from a placing of 58.3 million new shares at 6 pence each. The placing price is a discount of 16% from the stock's closing market price on Monday. The funds will be used to fund two drug trials through to completion, extending Poolbeg's cash runway into the second quarter of 2028. The share placing is run by broker Oak Securities. "This successful fundraise is a great market endorsement of Poolbeg, our strategy and pipeline," says Chief Executive Officer Jeremny Skillington. "Not only does it extend our expected cash runway into Q2 2028, but it strengthens the company's position in ongoing partnering discussions." Read More